| 5-FU | 5-Fluorouracil |
| CA | California |
| Cat | Catalogue number |
| cDNA | Complementary DNA |
| CSS | Charcoal-stripped bovine serum |
| Ct CT |
Cycle threshold Connecticut |
| DB | Database |
| DE | Differential expression |
| ECL | Enhanced chemiluminescence |
| ER | Oestrogen receptor |
| FBS | Fetal bovine serum |
| FDR | False discovery rate |
| g | Gravity |
| Gy | Gray |
| HKG | Housekeeping gene |
| IARC | International Agency for Research on Cancer |
| Inh | Inhibitor |
| IQR | interquartile range |
| IC50 | 50% inhibitory concentration |
| KO | Knockout |
| MA | Massachusetts |
| miRNA | MicroRNA |
| Mut | Mutant |
| NPC OAC PA |
Nasopharyngeal carcinoma Oesophageal adenocarcinoma Pennsylvania |
| PCR | Polymerase chain reaction |
| PE | Plating efficiency |
| PI | Propidium iodide |
| PPAR-α | Peroxisome proliferator-activated receptor alpha |
| RACS | Royal Australasian College of Surgeons |
| ROS | Reactive oxidative species |
| RP | Ribosomal protein |
| RT | Reverse transcription |
| SDS | Sodium dodecyl sulfate |
| SF UK |
Survival Fraction United Kingdom |
| USA Wa |
United States of America Washington |
| Wt | Wild-type |